Li Lab: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
(27 intermediate revisions by the same user not shown)
Line 15: Line 15:


==Recent News==
==Recent News==
. 12/2013: Kaifu's aging nucleosome paper accepted to ''' Genes & Development'''  
. 06/2013: Zheng's DaPars 3'UTR Pan Cancer analysis paper is accepted in principle in '''Nature Communications'''.


. 12/2013: We received a 5-year NIH/NHGRI '''R01''' grant to study DNA Methylation
. 08/2014: Liguo's RSeQC paper is ranked No. 15 in the [http://bioinformatics.oxfordjournals.org/reports/most-cited Most-Cited Articles] in Bioinformatics as of August 1, 2014.


. 11/2013: Wei will serve on the Editorial Board of '''Molecular Endocrinology'''
. 08/2014: '''Three Collaboration CPRIT grants''' are funded: DNA methylation with Goodell lab, 3'UTR with Wagner lab and ZM11 with Shi lab.


. 09/2013Deqiang's DNA methylation Canyon paper accepted to '''Nature Genetics'''.
. 08/2014Kaifu's "super promoter" paper is under review in '''Nature Genetics'''.  


. 09/2013Xueqiu's bisulfite sequencing quality control paper (BSeQC) accepted to '''Bioinformatics'''.
. 06/2014Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to '''Cell Stem Cell '''.  


. 08/2013Yuanxin's transcription elongation paper in revision in '''Nature'''.
. 06/2014Zheng's alternative splicing paper (with the Cooper Lab) is accepted to '''Molecular Cell '''.  


. 08/2013Kadir's p53 paper accepted to '''Nucleic Acids Research'''
. 04/2014Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in '''Nucleic Acids Research'''.


. 07/2013Deqiang's aging epigenomics paper was under external review in '''Cell'''.
. 02/2014DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in '''Cell Stem Cell'''.  


. 06/2013Our own DNA methylation bioinformatics '''R01 was scored at 6 percentile''' in its first submission.  
. 02/2014Zheng's collaborative work on alternative splicing in heart development is accepted to '''Nature Communications'''.  


. 06/2013:  Zheng's TCGA RNA-seq bioinformatics paper was under review in '''Nature Biotechnology'''.
. 02/2014:  Zheng's brain tumor 3'UTR regulator paper is accepted to '''Nature'''. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.


. 03/2013Eric joined the lab for his PhD thesis study. Welcome back, Eric!
. 02/2014Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.


. 01/2013Zheng's 3'UTR paper was in revision in '''Nature'''. Fingers Crossed!
. 02/2014Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to '''Cell Stem Cell'''.


. 01/2013[http://www.bcm.edu/news/item.cfm?newsID=6723 BCM News] and  [http://epigenie.com/danpos-reveals-dynamic-nucleosomes Epigenie Headline] about our recent work on nucleosome dynamics.
. 01/2014Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to '''Genome Biology'''.


. 12/2012Liguo and HJ's CPAT RNA coding potential prediction paper accepted to '''Nucleic Acids Research'''.
. 01/2014Our collaborative work on Breast Cancer Epigenetics is accepted to '''Science Translational Medicine'''.


. 11/2012Kaifu's nucleosome methodology paper DANPOS accepted to '''Genome Research'''.
. 01/2014Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to '''Nature'''. This work links transcription elongation to tumor suppression.


. 10/2012: Kaifu's promoter nucleosome paper accepted to '''Genome Research'''.
. 12/2013: Kaifu's aging nucleosome paper is accepted to ''' Genes & Development'''  


. 09/2012: A '''NIH R01 grant''' was funded. We will work with Dr. Issa at Temple Univ. to understand DNA methylation in Cancer.
. 12/2013: We received a 5-year NIH/NHGRI '''R01''' grant (scored at 6 percentile in its first submission) to study DNA Methylation


. 08/2012: A mouse ES nucleosome paper from Kaestner lab at Upenn was accepted to '''Cell'''. Kaifu and Wei used DANPOS to analyze the data and were listed as co-authors.
. 11/2013: Wei will serve on the Editorial Board of '''Molecular Endocrinology'''


. 08/2011: Dr. Benjamin Rodriguez will join us as a '''Postdoc Associate'''. Ben has PhD in Integrated Biomedical Science from the Ohio State Univ. Welcome!
. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to '''Nature Genetics'''.


. 08/2012A '''Mazzone Award ''' was funded. We will work with Dr. Balk at Harvard Medical School to understand the molecular features of aggressive prostate cancer.
. 09/2013Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to '''Bioinformatics'''.
. 06/2012: Liguo's RNA-seq Quality Control paper accepted to '''Bioinformatics'''.


. 06/2012A '''NIH R01 grant''' was funded. We will work with Dr. Goodell at BCM to understand DNA methylation in Hematopoietic Stem Cell.
. 08/2013Kadir's p53 paper is accepted to '''Nucleic Acids Research'''


. 04/2012A '''NIH R01 grant''' was funded. We will work with Dr. Dent at MD Anderson to define USP22 functions during mammalian development.
. 01/2013[http://www.bcm.edu/news/item.cfm?newsID=6723 BCM News] and  [http://epigenie.com/danpos-reveals-dynamic-nucleosomes Epigenie Headline] about our recent work on nucleosome dynamics.
 
. 04/2012:  Dr.Dean Tang's prostate cancer stem cell paper was accepted in '''Cell Stem Cell'''. Wei is a co-author.
 
. 02/2012:  Yuanxin's epigenetic paper with Katrin Chua lab at Stanford accepted to '''Nature'''. Two years of hard work finally paid off!
 
. 02/2012:  Liguo Wang was offered a '''tenure-track Assistant Professor''' position at Mayo Clinic. Congratulations!


. 02/2012:  Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!


[[Image:Banner.jpg‎‎]]
[[Image:Banner.jpg‎‎]]
Line 91: Line 82:
<div style="border-bottom: 1px dashed #9999CC;">
<div style="border-bottom: 1px dashed #9999CC;">


Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers with a Google Scholar H-index of 34.
Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.


We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.  
We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.  
Line 97: Line 88:
In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.
In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.


Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 in epigenetic regulation, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
* Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.


DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon.  
* DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.  


Nucleosome Organization: fragile nucleosome in stress-response, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.
* Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.


Transcriptome: chimeric RNA in prostate cancer,  Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.
* Transcriptome: chimeric RNA in prostate cancer,  Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


   
   

Revision as of 10:37, 12 August 2014

Home        People        Publications        Collaborations        Software        Positions        Contact       


Recent News

. 06/2013: Zheng's DaPars 3'UTR Pan Cancer analysis paper is accepted in principle in Nature Communications.

. 08/2014: Liguo's RSeQC paper is ranked No. 15 in the Most-Cited Articles in Bioinformatics as of August 1, 2014.

. 08/2014: Three Collaboration CPRIT grants are funded: DNA methylation with Goodell lab, 3'UTR with Wagner lab and ZM11 with Shi lab.

. 08/2014: Kaifu's "super promoter" paper is under review in Nature Genetics.

. 06/2014: Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to Cell Stem Cell .

. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to Molecular Cell .

. 04/2014: Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in Nucleic Acids Research.

. 02/2014: DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in Cell Stem Cell.

. 02/2014: Zheng's collaborative work on alternative splicing in heart development is accepted to Nature Communications.

. 02/2014: Zheng's brain tumor 3'UTR regulator paper is accepted to Nature. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.

. 02/2014: Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.

. 02/2014: Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to Cell Stem Cell.

. 01/2014: Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to Genome Biology.

. 01/2014: Our collaborative work on Breast Cancer Epigenetics is accepted to Science Translational Medicine.

. 01/2014: Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to Nature. This work links transcription elongation to tumor suppression.

. 12/2013: Kaifu's aging nucleosome paper is accepted to Genes & Development

. 12/2013: We received a 5-year NIH/NHGRI R01 grant (scored at 6 percentile in its first submission) to study DNA Methylation

. 11/2013: Wei will serve on the Editorial Board of Molecular Endocrinology

. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to Nature Genetics.

. 09/2013: Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to Bioinformatics.

. 08/2013: Kadir's p53 paper is accepted to Nucleic Acids Research

. 01/2013: BCM News and Epigenie Headline about our recent work on nucleosome dynamics.


News Archive




Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.

We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.

In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.

  • Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
  • DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.
  • Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.
  • Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


Lab Intranet openwetware


<html> <script type="text/javascript">

 var _gaq = _gaq || [];
 _gaq.push(['_setAccount', 'UA-5924762-2']);
 _gaq.push(['_trackPageview']);
 (function() {
   var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
   ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
   var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
 })();

</script> </html>